| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | Adherens junction 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2 | Adipocytokine signaling pathway 5 genes, 4 drugs (DrugBank) and 25 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 3 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 4 | AMPK signaling pathway 6 genes, 8 drugs (DrugBank) and 46 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 5 | Apelin signaling pathway 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 6 | Autophagy - animal 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 7 | Bile secretion 2 genes, 5 drugs (DrugBank) and 35 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 1件: NR1H4 |
D10699 |
Cholic Acid |
4件: 20, 234, 265, 310 |
| D09360 |
Obeticholic acid |
3件: 93, 265, 296 |
| 8 | Breast cancer 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 9 | cAMP signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 10 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 11 | Cholesterol metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: APOC3 |
D11648 |
Volanesorsen |
1件: 265 |
| 12 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 13 | Circadian rhythm 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 14 | Cytokine-cytokine receptor interaction 2 genes, 3 drugs (DrugBank) and 20 diseases shown |
1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 15 | EGFR tyrosine kinase inhibitor resistance 3 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 16 | Endocrine resistance 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 17 | Endocytosis 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 18 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 19 | Fluid shear stress and atherosclerosis 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 20 | Focal adhesion 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 21 | FoxO signaling pathway 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 22 | Glioma 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 23 | Glucagon signaling pathway 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 24 | Growth hormone synthesis, secretion and action 3 genes, 4 drugs (DrugBank) and 26 diseases shown |
1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: GHRHR |
D06655 |
Tesamorelin |
2件: 78, 265 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 25 | Hepatitis B 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 26 | Hepatitis C 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 27 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 28 | Herpes simplex virus 1 infection 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 29 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 30 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 31 | Human papillomavirus infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 32 | Human T-cell leukemia virus 1 infection 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 33 | Huntington disease 1 gene, 2 drugs (DrugBank) and 20 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 34 | Hypertrophic cardiomyopathy (HCM) 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 35 | Influenza A 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 36 | Insulin resistance 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 37 | Insulin signaling pathway 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 38 | JAK-STAT signaling pathway 4 genes, 4 drugs (DrugBank) and 26 diseases shown |
1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 39 | Kaposi sarcoma-associated herpesvirus infection 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 40 | Leishmaniasis 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 41 | Long-term depression 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 42 | Longevity regulating pathway 4 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 43 | Longevity regulating pathway - multiple species 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 44 | MAPK signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 45 | Measles 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 46 | Melanoma 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 47 | Metabolic pathways 1 gene, 3 drugs (DrugBank) and 32 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 48 | mTOR signaling pathway 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 49 | Necroptosis 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 50 | Neuroactive ligand-receptor interaction 3 genes, 4 drugs (DrugBank) and 20 diseases shown |
1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: GHRHR |
D06655 |
Tesamorelin |
2件: 78, 265 |
| 1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 51 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 52 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: LEPR |
D05014 |
Metreleptin |
1件: 265 |
| 1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 53 | Oocyte meiosis 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 54 | Osteoclast differentiation 2 genes, 3 drugs (DrugBank) and 25 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 55 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 56 | Oxytocin signaling pathway 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 57 | Pancreatic cancer 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 58 | Pathways in cancer 5 genes, 5 drugs (DrugBank) and 29 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 59 | PD-L1 expression and PD-1 checkpoint pathway in cancer 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 60 | PI3K-Akt signaling pathway 6 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: GHR, IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 61 | PPAR signaling pathway 3 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: APOC3 |
D11648 |
Volanesorsen |
1件: 265 |
| 1件: PPARA |
D00565 |
Fenofibrate |
5件: 8, 79, 93, 94, 265 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 62 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 63 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 64 | Prostate cancer 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
| D00957 |
| D00958 |
| D00959 |
| D06085 |
| D06087 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 65 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 66 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 67 | Ras signaling pathway 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 68 | Signaling pathways regulating pluripotency of stem cells 3 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 69 | Terpenoid backbone biosynthesis 1 gene, 3 drugs (DrugBank) and 32 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 70 | Th1 and Th2 cell differentiation 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 71 | Th17 cell differentiation 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 72 | Thermogenesis 3 genes, 3 drugs (DrugBank) and 27 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 73 | Thyroid cancer 1 gene, 2 drugs (DrugBank) and 20 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 74 | Tight junction 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 75 | Toxoplasmosis 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 76 | Transcriptional misregulation in cancer 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 77 | Tuberculosis 2 genes, 1 drug (DrugBank) and 8 diseases shown |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 78 | Viral carcinogenesis 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |